A

Alexion

Global biopharmaceuticals focusing on rare diseases

Associate Director 1/2 - Real World Data Statistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeBengaluru, Karnataka, IndiaNo salary listed

About the Job

Requirements

  • A PhD degree with a minimum of 7 years of relevant industry experience, or a Master’s degree with a minimum of 10 years of relevant industry experience.
  • An advanced degree or equivalent experience in statistics, biostatistics, or epidemiology.
  • Expert proficiency with R and/or SAS for analytics, and a solid understanding of SQL or Python for data engineering and validation.
  • A proven track record of generating real-world evidence for rare disease programs or patient populations.
  • Demonstrated ability to lead regulatory submissions using registry-based analyses and present in health authority or advisory settings.
  • Leadership in peer-reviewed publications or conference presentations in pharmacoepidemiology, methodology, or applied real-world evidence.
  • Extensive expertise in data quality assessment, cohort construction, linkage, and missing data strategies for registries.

Responsibilities

  • Oversee the statistical vision and analytical strategies for registry-based evidence, crafting regulatory submissions and decisions across rare disease programs.
  • Oversee the design, implementation, and validation of survival, causal inference, propensity score, and longitudinal models tailored for registry data, and produce analyses that meet global regulatory expectations.
  • Define, program, and implement robust, registry-specific statistical approaches addressing missingness, data linkage, confounding, and outcome validation; elevate practice through shared findings.
  • Provide leadership to clinical, epidemiology, regulatory, and registry operations teams; represent Alexion in external forums, advisory boards, and regulatory discussions.
  • Ensure alignment with AstraZeneca standard methodologies and guidance, including the FDA Real-World Evidence Framework and EMA registry guidance; ensure reproducibility, audit readiness, and transparent reporting in statistical deliverables.
  • Translate analytical results into narratives for executive leadership, briefing documents, and regulatory submissions, creating influence at the program level.
  • Serve as a mentor and coach to other Real World Data Statisticians within the team; build capability through knowledge-sharing, code review, and career development guidance.
  • Lead and oversee advanced statistical analyses of disease registry, patient registry, natural history study, electronic medical record, and claims data for regulatory submissions, including survival analysis, inference methods, propensity score matching, longitudinal modeling, and registry-specific approaches aligned with regulatory guidelines.
  • Drive cross-functional collaboration and partner with registry teams in regulatory interactions and advisory meetings, ensuring registry-derived analyses align with regulatory strategy and health authority expectations for FDA, EMA, and other global regulatory submissions.
  • Oversee development of regulatory-quality deliverables, including statistical analysis plans, tables, figures, listings, and regulatory briefing documents based on registry analyses, ensuring compliance with FDA Real-World Evidence Framework, EMA guidance on registry-based studies, and regulatory guidance documents.
  • Oversee development and validation of statistical methodologies for real-world evidence generation from registry sources that meet regulatory standards, and lead engagements with external registry investigators, statisticians, and regulatory consultants to ensure methodological rigor and alignment with regulatory requirements.
  • Mentor, guide, and support the professional development of other Real World Data Statisticians within the epidemiology team, building a high-performing, technically excellent function.

Desired Qualifications

  • Outstanding communication and influencing skills, with the ability to translate sophisticated concepts into clear recommendations for senior leadership.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs